The global benign prostatic hyperplasia surgical treatment market was valued at USD 2,042.94 million in 2024 and is projected to grow at a 5.3% CAGR between 2025 and 2034 .A segmentation-based lens illustrates how procedure types, end‑user settings, and emerging technologies inform product differentiation, application‑specific growth, value chain optimization, and segment‑wise performance...